Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients

Title
Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients
Authors
Keywords
Dengue fever, Viremia, Cytokines, Dose prediction methods, Hematocrit, Dengue virus, Platelets, Drug therapy
Journal
PLoS Neglected Tropical Diseases
Volume 10, Issue 8, Pages e0004851
Publisher
Public Library of Science (PLoS)
Online
2016-08-11
DOI
10.1371/journal.pntd.0004851

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started